Palisade Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Palisade Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-345,924	Closed	-$12.3M	–	373
2023 Q1	$12.3M	Sell	345,924 -347,806	-50%	-$12.6M	0.33%	101
2022 Q4	$25.4M	Sell	693,730 -33,765	-5%	-$1.33M	0.68%	48
2022 Q3	$34.3M	Buy	727,495 +2,217	+0.3%	+$143K	0.97%	20
2022 Q2	$52M	Buy	725,278 +9,991	+1%	+$730K	1.41%	6
2022 Q1	$57.9M	Sell	715,287 -42,267	-6%	-$3.58M	1.33%	5
2021 Q4	$77.8M	Sell	757,554 -51,209	-6%	-$4.92M	1.58%	1
2021 Q3	$70.8M	Buy	808,763 +77,256	+11%	+$6.99M	1.54%	2
2021 Q2	$65.5M	Sell	731,507 -6,875	-0.9%	-$581K	1.48%	1
2021 Q1	$56M	Buy	738,382 +32,679	+5%	+$2.46M	1.32%	8
2020 Q4	$48.1M	Buy	705,703 +49,011	+7%	+$3.06M	1.23%	7
2020 Q3	$34.9M	Buy	656,692 +53,272	+9%	+$3.17M	1.03%	11
2020 Q2	$35.1M	Buy	603,420 +17,477	+3%	+$939K	1.12%	8
2020 Q1	$23.1M	Sell	585,943 -30,341	-5%	-$1.77M	0.82%	22
2019 Q4	$36.7M	Buy	616,284 +30,217	+5%	+$1.62M	1.04%	13
2019 Q3	$31.2M	Buy	586,067 +71,213	+14%	+$3.65M	0.95%	18
2019 Q2	$26.3M	Buy	514,854 +25,350	+5%	+$1.18M	0.81%	24
2019 Q1	$25.3M	Sell	489,504 -91,425	-16%	-$4.43M	0.81%	24
2018 Q4	$22.9M	Sell	580,929 -187,073	-24%	-$8.69M	0.84%	21
2018 Q3	$39.6M	Sell	768,002 -16,651	-2%	-$815K	1.09%	14
2018 Q2	$36.8M	Buy	784,653 +156,883	+25%	+$6.49M	1.06%	14
2018 Q1	$22.3M	Buy	627,770 +157,884	+34%	+$6.18M	0.75%	30
2017 Q4	$20.5M	Buy	469,886 +28,111	+6%	+$1.31M	0.69%	39
2017 Q3	$23.1M	Buy	441,775 +8,177	+2%	+$456K	0.82%	30
2017 Q2	$25.4M	Buy	433,598 +31,151	+8%	+$1.62M	0.95%	13
2017 Q1	$18.5M	Sell	402,447 -21,061	-5%	-$1.05M	0.71%	38
2016 Q4	$22.3M	Sell	423,508 -47,615	-10%	-$2.31M	0.84%	24
2016 Q3	$21M	Buy	471,123 +140,735	+43%	+$6.1M	0.75%	27
2016 Q2	$12.6M	Buy	330,388 +24,359	+8%	+$1.07M	0.46%	61
2016 Q1	$12.6M	Buy	306,029 +162,527	+113%	+$6.7M	0.41%	70
2015 Q4	$6.96M	Buy	+143,502	New	+$6.38M	0.23%	151

Other funds holding SYNH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Palisade Capital Management's SYNH Position: Q2 2023 in Review

Palisade Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 345,924 shares — an estimated $12.3M sold.

Palisade Capital Management first reported a position in SYNH in Q4 2015 and held it in 30 quarters. The position peaked at $77.8M in Q4 2021. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

Palisade Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Palisade Capital Management sold 345,924 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $12.3M.
Palisade Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2015 and held it in 30 quarters.
Palisade Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $77.8M in Q4 2021.
317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Palisade Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.